Followers | 16 |
Posts | 1561 |
Boards Moderated | 0 |
Alias Born | 02/27/2014 |
![](https://investorshub.advfn.com/uicon/455402.png?cb=1599005025)
Sunday, October 04, 2020 1:18:31 PM
Remdesivir, manufactured by Gilead Sciences, works by lowering the amount of virus in the body. Clinical trial data published in May found that the drug reduced patients' length of hospital stay by about four days, from 15 days to a median of 11 days.
https://www.nbcnews.com/health/health-news/trump-receiving-remdesivir-antiviral-drug-part-experimental-treatment-n1241974
Would they be willing to gamble and try to get Lenzilumab involved to cut that # of days again so he can rush back to the Campaign Trail in healthier form? He may not need Lenz, or multiple days in the Hospital, but would they gamble with a President to get him out faster, or will they play it safe? Campaign or not would they be throwing everything at him or standby and see where his health is in a few more days? I am torn that he will be pushing to get out, but think Doctors will try to watch progression. Curious as to who is calling the Shots at this point with a President's health, is it him or is it Doctors Orders?
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM